Daxor Corporation Awarded New Patent For Remote Monitoring Of Blood Volume
Portfolio Pulse from Benzinga Newsdesk
Daxor Corporation (NASDAQ:DXR), a global leader in blood volume measurement technology, has been granted a new patent for a system that provides remote blood volume monitoring. The patent covers various methods, including wearable devices like smartwatches. The technology will help optimize ongoing care based on the patient's evolving blood volume status. This addition to Daxor's intellectual property portfolio is part of the company's strategy to fuel future product development.
November 09, 2023 | 1:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Daxor Corporation has been granted a new patent for remote blood volume monitoring. This could potentially enhance the company's product offerings and strengthen its position in the market.
The new patent could potentially enhance Daxor's product offerings and strengthen its position in the market. This could lead to increased sales and revenue, which would likely have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100